The Role of Interleukin-22 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis

The Role of Interleukin-22 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis

Background: Rheumatoid Arthritis (RA) is a chronic autoimmune disease that primarily affects small joints, resulting in joint inflammation, pain, and limited mobility. The identification of novel biomarkers specific to RA could enhance early diagnosis and treatment and also improve the monitoring o...

Full description

Bibliographic Details
Main Authors:	Shihab Almurshedi, Raad Alasady
Format:	Article
Language:	English
Published:	Faculty of Medicine, University of Kufa 2023-06-01
Series:	مجلة الكوفة الطبية
Subjects:	Arthritis (RA) Clinical Disease Activity Index (CDAI) DAS-28 CRP DAS-28 ESR Interleukin 22 (IL-22)
Online Access:	https://journal.uokufa.edu.iq/index.php/kmj/article/view/12223

Similar Items

The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Mahmood Almurshedi, et al.
Published: (2023-08-01)

Role of Cathepsin G in Rheumatoid Arthritis Diagnosis and Disease Activity Evaluation
by: Mays Saleh Khamees, et al.
Published: (2024-06-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

DAS28-ESR and DAS28-CRP - are they Interchangeable in Measuring the Activity of Rheumatoid Arthritis in Response to Treatment with Biological Agents?
by: Tanya K. Shivacheva
Published: (2020-03-01)

Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience
by: H. Singh, et al.
Published: (2022-09-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
by: Vladimira Boyadzhieva, et al.
Published: (2018-11-01)

Relationship between vitamin D3 level and rheumatoid arthritis patients attending Rizgary Teaching Hospital in Erbil city
by: Banaz Abdulsattar Hamad, et al.
Published: (2017-08-01)

Characteristics of Anemia in Rheumatoid Arthritis
by: Anca BOBIRCA, et al.
Published: (2022-09-01)

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
by: Perebetyuk L.
Published: (2015-09-01)

Hematological markers and ultrasound 7-joint inflammation score as add-on tools in the assessment of inflammation in rheumatoid arthritis patients
by: Abd Elatif Ahmed Gaballah, et al.
Published: (2022-05-01)

Circulating Interleukin-23 Levels in Rheumatoid Arthritis and its Relationship to Disease Activity: a Systematic Review with Meta-Analysis
by: Ahmed Azzam, et al.
Published: (2023-04-01)

Frequency of Thyroid Disorders in Rheumatoid Arthritis Patients and its Association with Disease Activity: A Hospital Based Study
by: Safina Hameed Qureshi, et al.
Published: (2023-06-01)

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
by: Kirsten Janke, et al.
Published: (2022-12-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

The role of timely rheumatoid arthritis treatment effectiveness control
by: Larisa M. Musaeva, et al.
Published: (2023-11-01)

Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study
by: Takahiro Nishino, et al.
Published: (2023-03-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

Analysis of peripheral blood parameters for the diagnosis of inflammatory activity in rheumatoid arthritis
by: V. Muravyov, et al.
Published: (2022-03-01)

Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression
by: Zhu J, et al.
Published: (2021-05-01)

CD28− Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status
by: Charlotte Thompson, et al.
Published: (2020-05-01)

Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis
by: Rama Hussein, et al.
Published: (2023-03-01)

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis
by: Brian C. Sauer, et al.
Published: (2020-10-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study
by: Mahmoud Gharib, et al.
Published: (2021-09-01)

Screening for depressive symptoms in patients with rheumatoid arthritis: relationship with pain severity, disease activity, and sleep quality
by: Adel Ibrahim Azzam, et al.
Published: (2022-09-01)

Association of positive psychological variables with disease activity, functional disability and erythrocyte sedimentation rate in patients with rheumatoid arthritis: a preliminary study
by: K.C. Meléndez-Monreal, et al.
Published: (2023-03-01)

Anti-Müllerian hormone (ovarian reserve) in rheumatoid arthritis patients: correlation with disease activity
by: Traez Israel, et al.
Published: (2024-06-01)

Datasets of YY1 expression in rheumatoid arthritis patients
by: Jinpiao Lin, et al.
Published: (2016-12-01)

The Association of Interleukin-17 and ACCP levels with Rheumatoid arthritis patients and Control Groups
by: Haneen Jassim, et al.
Published: (2023-12-01)

The Role of IL-37 as an Anti-Inflammatory Biomarker in some Iraqi Rheumatoid Arthritis Patients and Its Correlation with DAS28
by: Sattar Brissm Hassan, et al.
Published: (2022-11-01)

IMPACT OF PREGNANCY ON THE ACTIVITY OF RHEUMATOID ARTHRITIS AND ITS THERAPY ACCORDING TO PROSPECTIVE FOLLOW-UP DATA
by: E. V. Matyanova, et al.
Published: (2015-09-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

DAS28 score vs. ultrasound examination for assessment of rheumatoid arthritis disease activity: comparison and discussion of pros and cons
by: Tacjana Anna Barczyńska, et al.
Published: (2015-09-01)

Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity
by: Benjamin Hur, et al.
Published: (2021-06-01)

Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort
by: Francesco Molica Colella, et al.
Published: (2023-03-01)

Endogenous stimulation is responsible for the high frequency of IL-17A-producing neutrophils in patients with rheumatoid arthritis
by: Maria Gonzalez-Orozco, et al.
Published: (2019-08-01)

Depressão, ansiedade e atividade de doença na artrite reumatóide Depression, anxiety and disease activity in rheumatoid arthritis
by: Antonio Filpi Coimbra da Costa, et al.
Published: (2008-02-01)

Diagnosis delay in Egyptian rheumatoid-arthritis-patients: underlying factors and outcomes — retrospective observational study
by: Sarah A. Sakr, et al.
Published: (2023-06-01)